TGFB1 and cancer: In contrast, TGF‐β functionally switches to a pro‐tumorigenic signal when the tumor advances toward malignancy, instigating aggressive tumor characteristics such as cancer cells' immune evasion, alteration of the tumor microenvironment, and epithelial‐mesenchymal transition.